Search results
Showing 496 to 510 of 666 results for kidney or kidneys or renal
NICE has developed a medtech innovation briefing (MIB) on OCS Heart system for heart transplant .
NICE has developed a Medtech Innovation Briefing (MIB) on the AccuVein AV400 for vein visualisation
Neonatal infection: antibiotics for prevention and treatment (NG195)
This guideline covers preventing bacterial infection in healthy babies of up to and including 28 days corrected gestational age, treating pregnant women whose unborn baby is at risk of infection, and caring for babies of up to and including 28 days corrected gestational age with a suspected or confirmed bacterial infection. It aims to reduce delays in recognising and treating infection and prevent unnecessary use of antibiotics. The guideline does not cover viral infections.
Suspected sepsis in people aged 16 or over: recognition, assessment and early management (NG253)
This guideline covers the recognition, diagnosis and early management of suspected sepsis in people aged 16 or over who are not and have not recently been pregnant. It includes recommendations on recognition and early assessment, initial treatment, escalating care, finding and controlling the source of infection, early monitoring, information and support, and training and education.
Evidence-based recommendations on isatuximab (Sarclisa) plus bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma in adults when an autologous stem cell transplant is unsuitable.
Show all sections
Percutaneous transluminal renal sympathetic denervation for resistant hypertension (IPG754)
We have moved interventional procedures guidance 754 to become HealthTech guidance 662. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Laparoscopic renal denervation for loin pain haematuria syndrome (IPG709)
We have moved interventional procedures guidance 709 to become HealthTech guidance 596. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued
Source guidance details Comes from guidance Chronic kidney disease: assessment and management Number NG203 Date issued